What is Opus Genetics's research and development expense?

Opus Genetics (IRD) reported research and development expense of $10.58M in Q1 2026.

How has Opus Genetics's research and development expense changed year-over-year?

Opus Genetics's research and development expense increased by 33.0% year-over-year, from $7.95M to $10.58M.

What is the long-term trend for Opus Genetics's research and development expense?

Over 4 years (2021 to 2025), Opus Genetics's research and development expense has grown at a 19.4% compound annual growth rate (CAGR), from $15.17M to $30.81M.

Opus Genetics IRD Research and development expense

Research and development expense at other companies

AbbVieABBV

——

4D Molecular TherapeuticsFDMT

——

Segments

By product

See full

First Licensed Product$700K—

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's research and development expense?: Opus Genetics (IRD) reported research and development expense of $10.58M in Q1 2026.
How has Opus Genetics's research and development expense changed year-over-year?: Opus Genetics's research and development expense increased by 33.0% year-over-year, from $7.95M to $10.58M.
What is the long-term trend for Opus Genetics's research and development expense?: Over 4 years (2021 to 2025), Opus Genetics's research and development expense has grown at a 19.4% compound annual growth rate (CAGR), from $15.17M to $30.81M.